Skip to main content
. 2012 Mar;18(3):484–487. doi: 10.3201/eid1803.111266

Table 2. Campylobacter-specific laboratory practices for 107 Pennsylvania laboratories performing testing of stool specimens, 2009*.

Laboratory practice/method No. (%) laboratories
Included in routine testing 104 (97.2)
Special request culture 1 (0.9)
Culture plus antigen testing 1 (0.9)
Perform culture on positive antigen assay 2 (1.9)
Campylobacter antigen testing only 17 (15.8)
Culture broth enrichment usage
Yes (9 Campy-Thio, 1 GNB, 4 unspecified) 14 (13.1)
No 89 (83.2)
No response 4 (3.7)
Length of Incubation, h
24 1 (<1)
48 64 (59.8)
72 33 (30.8)
No response 9 (8.4)
Type of medium used for Campylobacter culture
Campy-BAP 65 (60.7)
CVA 30 (27.8)
Skirrow 2 (1.9)
CSM 2 (1.8)
CCDA or mCCDA 0
Not specified or not cultured 8 (7.5)
Temperature used for culture, °C
37 3 (2.8)
42 96 (89.7)
Not specified 8 (7.5)
Atmosphere used for culture
Microaerobic, 5% O2 96 (89.7)
10% CO2 1 (0.9)
Both 1(0.9)
Not specified 9 (8.4)
Tests used for identification of Campylobacter spp.
Gram stain 96 (89.7)
Oxidase 92 (86)
Catalase 70 (65.4)
Hippurate hydrolysis 51 (47.7)
Naladixic acid/cephalothin disk identification 21 (19.6)
Indoxyl acetate 7 (6.5)
Send to a reference laboratory 6 (5.6)
Other, not specified 33 (30.8)
Performs susceptibility testing 4 (3.7)

*Campy-Thio, Campylobacter thioglycollate broth; GNB, gram-negative broth; Campy-BAP, Campylobacter blood agar plates; CVA, cefoperazone-vancomycin-amphotericin; CSM, charcoal-based selective medium; CCDA, charcoal-cefoperazone-deoxycholate agar; mCCDA, modified CCDA.